Study S000433

Cardiovascular Outcomes of Type 2 Diabetic Patients Treated With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Real-life. An Observational Study Using Clinical-administrative Data

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04184947
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 10000
Start: 2014-03-01
Primary completion: 2018-12-31
Lead sponsor: University of Padova
Conditions: Type 2 Diabetes
Interventions: DRUG:SGLT2 inhibitor; DRUG:GLP-1 receptor agonist
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

3 point major adverse cardiovascular events (4P-MACE) [3-26 months after index date]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0010149	Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life. Longato E, BMJ open diabetes research & care	2020	Nonrandomized study	PMID 32591373 DOI	cites ClinicalTrials.gov:NCT04184947; registry reference DERIVED:32591373